High expression of LC3 combined with high levels of ALDH1 is associated with shorter overall survival and disease-free survival in pancreatic cancers patients, making coexpression of LC3/ALDH1 a valuable prognostic PDAC marker (18). The gene discussed is MAP1LC3A; the disease is pancreatic neoplasm.